As evidence of tirzepatide’s efficacy mounts across a range of cardiometabolic conditions, Eli Lilly has shown that taking the incretin medicine alongside another of its drugs, Taltz, could lead to better outcomes for patients living with both psoriatic arthritis and
read moreIn a saga that has spread over seven years, the FDA has again rejected Vanda’s bid to expand the label for Hetlioz to treat jet lag disorder. The new rejection came three months after the FDA said it would re-evaluate
read moreShortly after floating a contingency plan for its asset, vilobelimab—which boasts an emergency use authorization for COVID-19 in the U.S.—Germany’s InflaRx is drafting bigger changes to its organization as it looks to cut costs and focus attention on a separate
read more
Partnership will analyse m6A RNA modifications in patient samples to support development of STC‑15 More: Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies Source: News
read more
The first Excellence in Healthcare Partnerships (EHP) Awards and Networking Evening is afoot More: Excellence adventure Source: News
read moreSuarez will return to the U.S. as SVP and president, head of the U.S. biopharmaceuticals business unit, after five years posted in Madrid as head of the company’s Spain division. More: AZ taps Spain head Rick Suarez to lead US
read more© 1994 - 2026 B.M. Pharmaceuticals